Postingan

Menampilkan postingan dari April, 2021

CareLineLive secures £1.2 million funding to support digitalisation and innovation within the homecare sector

Led by Haatch Ventures, the investment will support CareLineLive’s international expansion and grow headcount London, UK; 19th April 2021: CareLineLive, the homecare management software that increases efficiency, capacity, compliance and communication between managers and carers by digitising their workflows, today announced that it has fundraised £1.2 million to support its national and international expansion. The investment, led by Haatch Ventures, will see CareLineLive’s headcount continue to grow, with a 30% headcount increase already seen since September 2020. Alongside this, the investment will accelerate CareLineLive’s expansion into international markets, with 10% of its customers currently outside the UK, including recent client wins in Australia, Malta and Zimbabwe. Josh Hough, Founder and MD, CareLineLive, commented: “Homecare is in need of modernisation globally and technology is helping to revolutionise the way it is provided for agencies, carers and their clients. Rec...

Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee 

With the acquisition of Mestex AG, Grünenthal secures global rights for an attractive late-stage asset that could offer an innovative therapy option for millions of patients affected by pain related to osteoarthritis of the knee. MTX-071 (resiniferatoxin) is a highly potent Transient Receptor Potential Vanilloid 1 (TRPV1) agonist. Its administration can reversibly defunctionalise TRPV1-expressing nociceptors. This can result in long lasting pain relief. Aachen, Germany, 12 April 2021 – Today, Grünenthal has announced the acquisition of Mestex AG through the takeover of all of its shares and options. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee. The investigational medicine is currently concluding Phase II of clinical development and is about to enter Phase III. Initial data showed a long-lasting and significant analgesic e...

REaD Group and Marie Curie Celebrate Award Success with Multi Award-Winning Insight Project

But the real winner is dataLondon, 5 August 2019 – Marketing data and insight agency REaD Group has further cemented its success in data-driven and insight marketing after winning a number of awards at two separate industry events, and being shortlisted for a further three categories in a third.Alongside Marie Curie, REaD Group was named as winner of the Best Use of Insight Award at the IoF National Fundraising Awards on 2nd July for the Big SHIFT project. The National Fundraising Awards celebrate the very best in fundraising and are a unique opportunity to showcase excellence in the charity fundraising sector.The award follows swiftly on the heels of REaD’s win at the Insight in Fundraising Awards in June. Together with Marie Curie, REaD took home the Most Powerful Insight using Data Analysis award. The awards recognise the best work, innovation and inspirational stories of individuals working in data, analysis and insight contributing to fundraising practices.REaD was also shortliste...

Trialbee are Looking for Volunteers with Eczema for Clinical Trial

Is eczema a part of your life? Volunteers needed for clinical trialTrialbee has now made it possible for about 80 candidates with eczema to volunteer in a medical research study around North Yorkshire & Sheffield. The screening period starts mid- September but pre sign-up is already possible. Get started.How can I participate?To be eligible, you must be:18 years of age or olderDiagnosed with moderate to severe eczemaAdvised not to apply creams or moisturizers for dry skinPurpose of the study: The purpose of this study is to explore the efficacy and safety of an investigational treatment for everyone with moderate to severe eczema (atopic dermatitis). Clinical and non-clinical studies have found there is a realistic expectation that this treatment will provide meaningful therapeutic benefit in eczema. Sign UpAbout TrialbeeTrialbee facilitates patient recruitment communication and cooperation between the various players involved in the entire clinical trial process. The company is sp...

University of New England Delivers Cutting Edge Virtual Reality Nursing Education with Oxford Medical Simulation

Virtual Reality (VR) simulation allows nursing students at the University of New England to practice caring for acutely ill virtual patients within an immersive, realistic setting. Training healthcare professionals using VR serves to support clinical skill development, thereby advancing safe, high quality patient care. BOSTON, MA, Nov. 6th, 2019 - The University of New England (UNE) is working with Oxford Medical Simulation (OMS) to deliver state-of-the-art virtual reality software to transform nursing education. The immersive virtual reality platform supports nursing students at the UNE School of Nursing and Population Health in providing simulated patient care to advance clinical decision making and communication skills with other health care providers. This training allows nursing students to practice in true-to-life virtual scenarios without posing risk or harm to patients and families.The technology is developed by Oxford Medical Simulation, an award-winning VR simulation company ...

Fresenius Kabi starts United for Clinical Nutrition initiative in Europe with first-of-its-kind clinical study assessing critically ill patients in 11 European countries

BAD HOMBURG, GERMANY – [November 18, 2019] The first patients are about to be enrolled in the EuroPN survey, a clinical study that will assess the nutritional balance and focus on functional outcomes of critically ill patients in about 100 hospitals across 11 European countries. The survey is an important scientific project by United for Clinical Nutrition (UFCN), a global initiative that strives to fight hospital malnutrition and its detrimental effects on patient outcomes. Healthcare professionals in about 100 hospitals from Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, Spain, Sweden and the United Kingdom will collect data on the nutritional status of their patients as well as caloric and protein intake during ICU stay. Caloric and protein balance will be related to clinical outcomes, with a focus on measures of physical function. The collected data will provide insights into the current practice of clinical nutrition in critically ill patients and...

e-days partners with Doctor Care Anywhere so businesses can direct employees straight to virtual GP services

- New partnership first of its kind to link absence management systems to on-demand medical healthcare and advice- As Coronavirus spreads, Doctor Care Anywhere fielding hundreds of calls per day, relieving pressure on NHS London, UK: 17th March 2020: Employees can now access virtual GP services via their company’s absence management system, following a partnership between e-days, the leader in global absence intelligence, and Doctor Care Anywhere. The announcement sees e-days, the global absence management and intelligence platform, offer integrated real-time wellbeing resources to workers. For the first time ever, companies will be able to link employee absence data and employee wellbeing by providing targeted services and resources to get them well more quickly. This comes at a particularly poignant time as concerns grow for the spread of COVID-19 in the UK. The solution is designed to give employees 24/7 access to GP bookings, for video or telephone-based consultations, at t...

€1.5 million to increase the quality at the end of life

Zurich, July 7, 2020 – We+Care, the Swiss care coordination pilot project received funding from the EU’s AAL innovation promotion program for a three-year international research and development project called “Quality of Life at the End of Life”, which aims to improve the quality of life of care recipients at the end of life, their family caregivers and inter-professional teams from care providers. Initiated in 2018, We+Care is tapping the untapped knowledge of family carers and helps creating the right care solution by making informed decisions on how to setup and coordinate a care network optimizing the resources efficacy of integrated care groups. The «QEoL» project will help We+Care extend its proposition to remote palliative care cases, supporting connected families to fulfil last wishes using immersive and assistive technology. Funding for the project totals €1.5 million; of which €0.8 million represents public funding from the AAL Association, leading the Ambient Assisted Livi...

Half of all NHS trusts in England opt for UK tech company StarLeaf over video conferencing rivals

Watford-headquartered StarLeaf is a privacy-centric, British competitor to Zoom Over 100 NHS organisations across England are using StarLeaf video meetings and chat to keep both internal and external teams connected and make sure medical appointments, training and recruitment take place Over 50,000 medical professionals are registered users of StarLeaf across these organisations, making over half a million video call minutes each day StarLeaf is facilitating 11,181 scheduled NHS meetings each day, and has played a vital role in helping the NHS go virtual during the pandemic Watford,11th November 2020 - Video meetings provider StarLeaf is working with over 100 English NHS organisations, helping them to communicate and collaborate remotely, train and recruit staff and keep vital treatment, clinics and consultations going, as social distancing measures remain in place. During the initial stages of the Coronavirus pandemic in the spring the NHS was forced to dramatically change the ...

CareLineLive secures £175k funding from Innovate UK to accelerate digital transformation of homecare market

The grant for Sustainability & Innovation has been awarded to CareLineLive to develop data insights and further the functionality for its homecare platform that connects agencies, clients, carers and families London, UK; 18th March 2021: CareLineLive, the all-in-one home care management software that increases efficiency, capacity, compliance and communication of both managers and carers by digitising their work flows, today announced that it has secured a £175k grant from the UK’s innovation agency, Innovate UK. The Innovate UK funding supports a research-led software development project that extends the capability of CareLineLive to provide dynamic care planning of patients in their homes. With the Care Quality Commission (CQC) pushing for digitalisation of the sector, the project will result in more efficient data capture of a patient’s physical and mental welfare. This will ultimately improve patient care in a market that is traditionally fragmented and uses paper-based or ...

RIVIAM Digital Care is awarded funding from Innovate UK to enhance its new social prescribing platform used in Bath and North East Somerset to transform the way health, social care and third sector organisations are co-ordinating care

22nd July 2020 – RIVIAM Digital Care has been awarded £48,450 funding by Innovate UK to enhance its new social prescribing platform. RIVIAM’s Wellbeing platform is currently used in Bath and North East Somerset (BaNES) by Virgin Care, BaNES Council and many third sector organisations, including Age UK BaNES, Citizens Advice BaNES and Bath Mind, to co-ordinate the provision of food, mental health, wellbeing and welfare support for vulnerable people during the Covid-19 pandemic. Since April 2020, approximately 1500 cases and just under 6500 calls for support have been managed quickly and efficiently by partner organisations collaborating together online using RIVIAM in a Compassionate Community Hub. The funding provided by Innovate UK, the UK’s Innovation Agency, will be used by RIVIAM to extend its current Wellbeing social prescribing service, transforming the ability for health, social care and third sector organisations to work together. New capabilities will enable authorised u...

Wyld Networks works with NHS Highland and Highland Health Ventures to integrate mesh technology into new mobile app to help prevent spread of COVID-19 in care homes

Specialist app will provide safer environments and better communications by creating geozones 20 May 2020: Wyld Networks has signed an agreement with Highland Health Ventures Ltd (HHVL) to test and deploy its mobile mesh technology into care homes in Scotland to help protect residents, staff and visitors and prevent the spread of COVID-19 or other viruses. HHVL is an independent company with a Collaboration Agreement with NHS Highland for the purpose of developing innovations in healthcare. The Wyld technology will provide digital access and anonymised social distance monitoring and alerting through a mobile app and a mesh wireless network of connected smartphones and IoT (Internet of Things) devices. Wyld and HHVL have already started the first project for implementation in a care home in Scotland, while the technology may also have broader applications in helping other businesses get back to work. Statistics from the National Records of Scotland (NRS) show that more than half of t...